Palasis Maria
- SEC CIK
- 0001810701
In the past year, 3 open-market sale filings worth $85.1K and no purchases.
Current role at each company
- BBNX Beta Bionics, Inc.Directoras of May 26, 2026
- LYRA Lyra Therapeutics, Inc.Principal Executive Officeras of Apr 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $85.1K
- 3 filings
- Net
- −$85.1K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Palasis Maria as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LYRA Lyra Therapeutics, Inc.
Principal Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Palasis MariaPresident & CEO | SSale | −1.70K | $3.36 | −$5.72K | −0.2%1.10M after | 10b5-1 |
| Jul 14, 2025 (view filing) | Jul 10 | 4 days | Palasis MariaPresident & CEO | SSale | −1.56K | $8.91 | −$13.9K | −0.1%1.10M after | 10b5-1 |
BBNX Beta Bionics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 (view filing) | Dec 1 | 1 day | Palasis MariaDirector | SSale | −1.41K | $29.55 | −$41.6K | −14.3%8.44K after | 2 lots10b5-1 |
| Nov 5, 2025 (view filing) | Oct 31 | 5 daysLate | Palasis MariaDirector | SSale | −1.41K | $26.91 | −$37.8K | −12.5%9.84K after | 2 lots10b5-1 |